Benralizumab 30mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £109,771,295 of indicative cost of Benralizumab 30mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is up 17.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Benralizumab 30mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Benralizumab 30mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £16,222,590 |
| Manchester University Nhs Ft | £8,854,195 |
| University Hospital Southampton Nhs Ft | £6,379,165 |
| Portsmouth Hospitals Nhs Trust | £4,869,905 |
| University Hospitals Plymouth Nhs Trust | £4,703,730 |
| Cambridge Univ Hosp Nhs Foundation Trust | £4,175,880 |
| Oxford University Hospitals Nhs Ft | £3,863,080 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £3,700,815 |
| Barts Health Nhs Trust | £3,431,025 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,237,480 |
The primary-care picture
Benralizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Benralizumab medicine page.